Search Results

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global healthcare analytical testing services market has gathered pace in its growth due to the enormous demand for research and development outsourcing.

The testing and analysis services market is fairly fragmented with the presence of a number of small players offering services at competitive pricing, notes Transparency Market Research.

The global healthcare analytical testing services market has gathered pace in its growth due to the enormous demand for research and development outsourcing.

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, announced new preclinical data from its exoVACC™ exosome-based vaccine platform.

Combined expertise in engineered exosomes and antigen prediction could drive a new approach to vaccine development - - engEx™ exosomes incorporating both B cell and T cell antigens plus adjuvants have potential to produce integrated immune response -

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has made three senior appointments to its Analytical Services Division.

exoVACC™ modular vaccine platform induces potent systemic and tissue resident T cell response - - Engineered exosomes allow for targeting of multiple cell types - CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Codiak BioSciences, Inc., a company at the forefront of advancing engineered exosomes as a new class of biologic medicines, today announced new preclinical data on programs using its proprietary engEx Platform. Highlights include new preclinical

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, reported third quarter 2022 financial results and recent operational progress.